New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
07:04 EDTCASICASI Pharmaceuticals' receives approval from CFDA to conduct clinical trial
CASI Pharmaceuticals announced that China's Food and Drug Administration, or CFDA has approved the Company's application to conduct a Phase II clinical trial in triple-negative breast cancer patients in China for its proprietary drug candidate, ENMD-2076.
News For CASI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
07:05 EDTCASICASI Pharmaceuticals granted Type C meeting with FDA for carcinoma candidate
Subscribe for More Information
December 12, 2014
16:56 EDTCASICASI Pharmaceuticals files to sell 5.4M shares of common stock for holders
Subscribe for More Information
December 8, 2014
12:28 EDTCASICASI Pharmaceuticals to host special shareholder meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use